Rockwell Medical Company Profile (NASDAQ:RMTI)

About Rockwell Medical

Rockwell Medical, Inc. (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its lead branded drug, Triferic is indicated for iron maintenance. Triferic is an iron compound that is delivered to hemodialysis patients through dialysate, replacing the iron loss that occurs during their dialysis treatment. Its generic drug, Calcitriol, is indicated for treating secondary hyperparathyroidism in dialysis patients. It manufactures, sells, delivers and distributes hemodialysis concentrates, along with a range of ancillary products.

Industry, Sector and Symbol:

Sector: Medical
Industry: Drug Manufacturers - Major
Sub-Industry: Health Care Equipment
Exchange: NASDAQ
Symbol: RMTI
CUSIP: 77437410

Key Metrics:

Previous Close: $6.38
50 Day Moving Average: $7.12
200 Day Moving Average: $7.78
52-Week Range: $5.47 - $13.50
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -319.00
P/E Growth: -0.92
Market Cap: $328.74M
Outstanding Shares: 51,526,000
Beta: 1.68

Profitability:

Net Margins: -33.04%
Return on Equity: -28.90%
Return on Assets: -19.91%

Debt:

Current Ratio: 9.16%
Quick Ratio: 7.96%

Additional Links:

Companies Related to Rockwell Medical:

Consensus Ratings for Rockwell Medical (NASDAQ:RMTI) (?)

Ratings Breakdown:	2 Sell Ratings, 3 Hold Ratings, 2 Buy Ratings
Consensus Rating:	Hold (Score: 2.00)
Consensus Price Target:	$11.60 (81.82% upside)

Analysts' Ratings History for Rockwell Medical (NASDAQ:RMTI)

Show:

Date	Firm	Action	Rating	Price Target
9/22/2016	BTIG Research	Reiterated Rating	Buy	$12.00
4/6/2016	Morgan Stanley	Reiterated Rating	Sell
3/3/2016	Bank of America Corp.	Reiterated Rating	Neutral	$18.00 -> $9.00
3/1/2016	Craig Hallum	Downgrade	Buy -> Hold	$7.00
3/1/2016	Stifel Nicolaus	Downgrade	Buy -> Hold
11/12/2015	Oppenheimer Holdings Inc.	Reiterated Rating	Outperform	$26.00
11/11/2015	Brean Capital	Reiterated Rating	Sell	$4.00
1/27/2015	Summer Street	Set Price Target	Positive -> Buy	$25.00
11/11/2014	Chardan Capital	Reiterated Rating	Positive
10/8/2014	ING Group	Reiterated Rating	Buy

(Data available from 9/27/2014 forward)

Earnings History for Rockwell Medical (NASDAQ:RMTI)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/7/2016
8/8/2016	Q2	($0.10)	($0.11)	$13.86 million	$12.50 million	View	N/A
5/10/2016	Q1	($0.08)	($0.10)	$15.25 million	$13.63 million	View	Listen
2/29/2016	Q4	$0.02	($0.12)	$19.98 million	$14.10 million	View	Listen
11/9/2015	Q315	($0.02)	($0.05)	$14.93 million	$14.40 million	View	Listen
8/4/2015	Q215	($0.10)	($0.05)	$11.84 million	$12.96 million	View	Listen
5/7/2015	Q414	($0.10)	($0.07)	$13.20 million	$13.90 million	View	N/A
2/26/2015	Q4	($0.10)	($0.14)	$13.51 million	$14.40 million	View	N/A
11/10/2014	Q314	($0.10)	($0.10)	$13.40 million	$13.70 million	View	N/A
7/31/2014	Q2	($0.13)	($0.08)	$13.45 million	$13.00 million	View	N/A
5/12/2014	Q1	($0.14)	($0.20)	$14.22 million	$13.00 million	View	N/A
2/26/2014		($0.28)	($0.21)			View	N/A
11/8/2012	Q312	($0.50)	($0.86)	$12.57 million	$12.70 million	View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Rockwell Medical (NASDAQ:RMTI)

Current Year EPS Consensus Estimate: $-0.36 EPS
Next Year EPS Consensus Estimate: $-0.02 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	($0.09)	($0.09)	($0.09)
Q2 2016	1	($0.06)	($0.06)	($0.06)
Q3 2016	1	($0.09)	($0.09)	($0.09)
Q4 2016	1	($0.09)	($0.09)	($0.09)

(Data provided by Zacks Investment Research)

Dividend History for Rockwell Medical (NASDAQ:RMTI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Rockwell Medical (NASDAQ:RMTI)

Insider Ownership Percentage: 15.90%
Institutional Ownership Percentage: 21.72%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/19/2016	Kenneth L Holt	Director	Sell	8,075	$6.81	$54,990.75
8/25/2016	Kenneth L Holt	Director	Sell	9,520	$6.37	$60,642.40
8/16/2016	Kenneth L Holt	Director	Sell	3,692	$7.31	$26,988.52
12/4/2015	Ronald D. Boyd	Director	Sell	12,500	$10.58	$132,250.00
8/14/2015	Robert L Chioini	CEO	Buy	4,910	$11.96	$58,723.60
8/13/2015	Raymond Dennis Pratt	VP	Buy	5,000	$11.54	$57,700.00
8/13/2015	Robert L Chioini	CEO	Buy	5,090	$11.51	$58,585.90
8/27/2012	David A Hagelstein	Major Shareholder	Buy	7,000	$8.10	$56,700.00

(Data available from 1/1/2013 forward)

Latest Headlines for Rockwell Medical (NASDAQ:RMTI)

Date	Headline
	Stock Tracker: Earnings & Estimates for Rockwell Medical, Inc. (NASDAQ:RMTI) - Frisco Fastball (NASDAQ:RMTI) friscofastball.com - September 25 at 6:16 PM
	Hot Line At Active Movers- MagneGas (NASDAQ:MNGA), Biostar ... - Seneca Globe (NASDAQ:RMTI) www.senecaglobe.com - September 23 at 6:34 PM
	Earnings Analysis & Update for Rockwell Medical, Inc. (NASDAQ:RMTI)? - Frisco Fastball (NASDAQ:RMTI) friscofastball.com - September 23 at 6:34 PM
	Rockwell Medical : Preparing for Calcitriol Commercial Launch (NASDAQ:RMTI) www.4-traders.com - September 23 at 11:48 AM
	Rockwell Medical Preparing for Calcitriol Commercial Launch (NASDAQ:RMTI) www.publicnow.com - September 22 at 11:53 AM
	Shares Of Rockwell Medical, Inc. (NASDAQ:RMTI) Expected To Hit $7 - Investor Newswire (NASDAQ:RMTI) www.investornewswire.com - September 19 at 6:59 PM
	Expected For Rockwell Medical, Inc. (NASDAQ:RMTI) Sales Of $147.19 - Investor Newswire (NASDAQ:RMTI) www.investornewswire.com - September 15 at 10:39 AM
	ETF’s with exposure to Rockwell Medical, Inc. : September 2, 2016 (NASDAQ:RMTI) www.capitalcube.com - September 2 at 11:59 AM
	Will Rockwell Medical, Inc. (NASDAQ:RMTI) Surprise This Quarter? - Investor Newswire (NASDAQ:RMTI) www.investornewswire.com - August 24 at 6:51 PM
	BTIG Sets $12 Price Target On Rockwell Medical, Sees 63% Upside (NASDAQ:RMTI) www.stockhouse.com - August 19 at 7:02 PM
	Rockwell Medical Stock Upgraded: What You Need to Know (NASDAQ:RMTI) www.fool.com - August 19 at 3:24 PM
	ROCKWELL MEDICAL, INC. Financials (NASDAQ:RMTI) finance.yahoo.com - August 18 at 7:27 PM
	Shares Moving Lower Over the Past Month Rockwell Medical, Inc. (NASDAQ:RMTI) - Post News (NASDAQ:RMTI) www.kentuckypostnews.com - August 18 at 10:11 AM
	Arab Financial Investment : Rockwell, ARAM sign agreement to commercialize Triferic in KSA, Egypt (NASDAQ:RMTI) www.4-traders.com - August 17 at 7:32 PM
	Rockwell Medical Enters into Exclusive License Agreement with ARAM Medical to Commercialize Triferic® in Saudi Arabia, Egypt and Middle East… (NASDAQ:RMTI) forextv.com - August 17 at 10:09 AM
	Will Rockwell Medical, Inc. (NASDAQ:RMTI) Hit $7 Price Target? - Investor Newswire (NASDAQ:RMTI) www.investornewswire.com - August 16 at 10:30 AM
	Rockwell Medical Technologies (RMTI), ARAM Medical Enter Exclusive License Agreement for Triferic - StreetInsider.com (NASDAQ:RMTI) www.streetinsider.com - August 16 at 10:30 AM
	Rockwell Medical Enters into Exclusive License Agreement with ARAM Medical to Commercialize Triferic® in Saudi Arabia, Egypt and Middle East Territories (NASDAQ:RMTI) www.publicnow.com - August 16 at 10:30 AM
	ETF’s with exposure to Rockwell Medical, Inc. : August 11, 2016 (NASDAQ:RMTI) www.capitalcube.com - August 11 at 7:42 PM
	Rockwell Medical, Inc. :RMTI-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:RMTI) www.capitalcube.com - August 10 at 7:41 PM
	Rockwell Medical, Inc. (NASDAQ:RMTI) Records An Estimated Annual Sales Mean Of $147.276 - Investor Newswire (NASDAQ:RMTI) www.investornewswire.com - August 10 at 10:17 AM
	Rockwell Medical, Inc.'s (RMTI) CEO Robert Chioini on Q2 2016 Results - Earnings Call Transcript - Seeking Alpha (NASDAQ:RMTI) seekingalpha.com - August 10 at 10:17 AM
	Noticeable Analyst's ideas: Rockwell Medical, Inc. (NASDAQ:RMTI) , Omeros Corporation (NASDAQ:OMER) - Street Updates (NASDAQ:RMTI) www.streetupdates.com - August 10 at 10:17 AM
	Rockwell Medical, Inc.'s (RMTI) CEO Robert Chioini on Q2 2016 Results - Earnings Call Transcript (NASDAQ:RMTI) seekingalpha.com - August 9 at 10:22 AM
	Rockwell Medical reports 2Q loss (NASDAQ:RMTI) sg.finance.yahoo.com - August 9 at 10:22 AM
	ROCKWELL MEDICAL, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:RMTI) biz.yahoo.com - August 9 at 10:22 AM
	Earnings Reaction History: Rockwell Medical Technologies Inc, 100.0% Follow-Through Indicator, 9.5% Sensitive (NASDAQ:RMTI) www.nasdaq.com - August 8 at 7:23 PM
	Rockwell Medical Inc.: Rockwell Medical Reports Second Quarter Results (NASDAQ:RMTI) www.twst.com - August 8 at 7:23 PM
	ROCKWELL MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex (NASDAQ:RMTI) biz.yahoo.com - August 8 at 7:23 PM
	Rockwell Medical Reports Second Quarter Results (NASDAQ:RMTI) www.publicnow.com - August 8 at 7:23 PM
	Q2 2016 Rockwell Medical Inc Earnings Release - After Market Close (NASDAQ:RMTI) biz.yahoo.com - August 8 at 11:54 AM
	Rockwell Medical Inc.: Rockwell Medical Schedules Second Quarter 2016 Earnings Call (NASDAQ:RMTI) www.twst.com - August 5 at 7:24 PM
	Rockwell Medical, Inc. (NASDAQ:RMTI) Yearly Sales Target At ... - Investor Newswire (NASDAQ:RMTI) www.investornewswire.com - August 4 at 7:39 PM
	Rockwell Medical Schedules Second Quarter 2016 Earnings Call - GlobeNewswire (press release) (NASDAQ:RMTI) globenewswire.com - August 3 at 7:31 PM
	Rockwell Medical Schedules Second Quarter 2016 Earnings Call (NASDAQ:RMTI) www.publicnow.com - August 3 at 7:31 PM
	Can Shares Of Rockwell Medical, Inc. (NASDAQ:RMTI) Hit $7? - Investor Newswire (NASDAQ:RMTI) www.investornewswire.com - July 27 at 7:34 PM
	Expected For Rockwell Medical, Inc. (NASDAQ:RMTI) Sales Of $147.276 - Investor Newswire (NASDAQ:RMTI) www.investornewswire.com - July 27 at 7:34 PM
	Rockwell Medical Inc (NASDAQ:RMTI) Stock Volatility Hits A Lowered Level - CML News (NASDAQ:RMTI) news.cmlviz.com - July 22 at 10:06 AM
	What Next for Rockwell Medical Inc Stock After Today's Huge Increase? - Press Telegraph (NASDAQ:RMTI) presstelegraph.com - July 21 at 10:01 AM
	Equity Roundup: Stock Performance Focus on Rockwell Medical, Inc. (NASDAQ:RMTI) - Press Telegraph (NASDAQ:RMTI) presstelegraph.com - July 21 at 10:01 AM
	Rockwell Medical Inc Stock Technicals at Critical Inflection Point - CML News (NASDAQ:RMTI) news.cmlviz.com - July 21 at 10:01 AM
	Earnings Focus and Crowd Sourced Sentiment Review for Rockwell Medical, Inc. (NASDAQ:RMTI) - TGP (NASDAQ:RMTI) telanaganapress.com - July 19 at 7:18 PM
	Rockwell Medical, Inc. (NASDAQ:RMTI) Expected To Post Sales Of $147.276 - Investor Newswire (NASDAQ:RMTI) www.investornewswire.com - July 19 at 7:18 PM
	Share Performance Summary for: Rockwell Medical, Inc. (NASDAQ:RMTI) - Press Telegraph (NASDAQ:RMTI) presstelegraph.com - July 19 at 8:08 AM
	Is $7 Price Target Attainable For Rockwell Medical, Inc. (NASDAQ:RMTI)? - Investor Newswire (NASDAQ:RMTI) www.investornewswire.com - July 19 at 8:08 AM
	Shares Experiencing a Downtrend: Rockwell Medical, Inc. (NASDAQ:RMTI) - TGP (NASDAQ:RMTI) telanaganapress.com - July 17 at 6:34 PM
	Rockwell Medical, Inc. (RMTI) Current Analyst Ratings - Fiscal Standard (NASDAQ:RMTI) www.fiscalstandard.com - July 17 at 6:34 PM
	Rockwell Medical, Inc. (NASDAQ:RMTI) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:RMTI) www.engelwooddaily.com - July 15 at 12:22 PM
	Rockwell Medical, Inc. (NasdaqGM:RMTI) Fundamental Star Rating Report - CML News (NASDAQ:RMTI) news.cmlviz.com - July 15 at 12:22 PM
	Rockwell Medical, Inc. (NASDAQ:RMTI) Yearly Sales Target At $147.276 - Investor Newswire (NASDAQ:RMTI) www.investornewswire.com - July 13 at 10:04 AM